Summary
Research into anticancer therapies has provided little progress towards improved survival rates for patients with metastatic disease. There exists growing concern about patient variability regarding the tumor pathophysiology that underlies therapeutic outcomes. Nanomedicine...
More information & hyperlinks
| Web resources: | http://vicentresearchlab.com |